TrialNeuro-oncology2014

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.

Orin Bloch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.